$0.37
$0.00 (0.00%)
End-of-day quote: 05/13/2024
NYSEAM:TOVX
Theriva Biologics Annual Report
| Year | Year | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2021 | 2022 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $2.61M | $0.00M | $0.00M | $0.00M | $0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -41.43% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-1.14 | $-1.31 | $-1.90 | $-63.00 | $-143.99 | $-173.14 | $-112.00 | $-94.50 | $-175.00 | $-74.42 | $-28.00 | $-122.50 | $-444.50 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Sha. | Shares |
|
0.37m | 0.33m | 0.26m | 0.21m | 0.17m | 0.13m | 0.09m | 0.07m | 0.06m | 0.06m | 13.2m | 15.12m | ||
| OCF | Operating Cash Flow |
|
$-20.20M | $-27.90M | $-38.89M | $-16.08M | $-7.72M | $-8.92M | $-2.88M | $-1.15M | $-4.85M | $-6.61M | $-12.89M | $-19.08M | ||
| FCF | Free Cash Flow |
|
$-20.41M | $-28.47M | $-39.39M | $-16.13M | $-7.76M | $-8.93M | $0.00M | $-1.16M | $-4.87M | $-8.58M | $-12.90M | $-19.20M | ||
| FCFS | Free Cash Flow Per Share |
|
$-57.46 | $-105.68 | $-170.83 | $-91.12 | $-59.43 | $-89.52 | $-36.31 | $-18.08 | $-82.59 | $-170.50 | $-1.06 | $-1.25 |
